Learn about our healthcare areas

Explore medicine and therapy products
Explore MedTech products

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Home/
      2. Media Center/
      3. Press releases /
      4. Innovative Medicine

      Innovative Medicine

      Innovative Medicine
      April 4, 2017

      Health Risk Assessments Shed Light on Early Predictors of Depression

      Learn more
      Innovative Medicine
      April 4, 2017

      U.S. FDA Accepts for Review the Application of Ibrutinib (IMBRUVICA®) for Chronic Graft-Versus-Host-Disease (cGVHD) After Failure of One or More Lines of Systemic Therapy

      Learn more
      Innovative Medicine
      April 3, 2017

      Janssen Collaborates with Premier Inc. on Unique Study to Improve Stroke Risk Management among Hospitalized Patients with Atrial Fibrillation

      The QUANTUM AF study will evaluate the impact of a hospital quality improvement program on the use of new guidelines to treat patients with atrial fibrillation (AF) at risk for ischemic stroke
      Learn more
      Corporate
      March 30, 2017

      Johnson & Johnson Innovation Launches Advancing the Safe Use of Healthcare Products QuickFire Challenge

      Challenge awards up to $200,000 to novel solutions that advance safety by informing patients and consumers, simulating surgical procedures or ensuring proper storage and use of prescription, over-the-counter and cosmetic products
      Learn more
      Innovative Medicine
      March 30, 2017

      Janssen Discontinues Development of Flubendazole Formulation to Treat Onchocerciasis

      Research supported Johnson & Johnson’s commitment to the 2012 London Declaration on Neglected Tropical Diseases and yielded important findings
      Learn more
      Global Health Equity
      March 23, 2017

      Johnson & Johnson Innovation launches Singapore QuickFire Challenge Competition in collaboration with ETPL and SMART to accelerate solutions for diabetes and other metabolic diseases

      Learn more
      Innovative Medicine
      March 18, 2017

      New Phase 3 Study Finds XARELTO® to Be Superior to Aspirin for Long-Term Prevention of Recurrent Blood Clots Without Observing any Significant Increase in Major Bleeding in Patients with Venous Thromboembolism

      Learn more
      Global Health Equity
      March 14, 2017

      Johnson & Johnson Reports that Investigational Ebola Vaccine Regimen Induced Durable Immune Response 1 Year After Vaccination in Phase 1 Study

      Learn more
      Global Health Equity
      March 14, 2017

      Johnson & Johnson Names Winners of First Africa Innovation Challenge

      Competition Part of Company’s Eighty-Five Year Commitment to Supporting Entrepreneurs, Science Education Opportunities, and Health Systems Across the Continent
      Learn more
      Load more